Codiak BioSciences, Inc. is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need.
Market Cap | 87.501 Million | Shares Outstanding | 22.494 Million | Avg 30-day Volume | 240.659 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -12.83 |
Price to Revenue | 10.9257 | Debt to Equity | 0.4753 | EBITDA | -29.142 Million |
Price to Book Value | 4.6833 | Operating Margin | -303.24399999999997 | Enterprise Value | 199.074 Million |
Current Ratio | 3.319 | EPS Growth | 0.895 | Quick Ratio | 2.832 |
1 Yr BETA | 1.513 | 52-week High/Low | 22.95 / 2.21 | Profit Margin | -162.01 |
Operating Cash Flow Growth | -17.0184 | Altman Z-Score | -1.4689 | Free Cash Flow to Firm | -99.963 Million |
Earnings Report | 2022-08-04 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
9,000 | 2022-06-17 | 2 | |
|
9,000 | 2022-06-17 | 2 | |
|
9,000 | 2022-06-17 | 2 | |
|
1,500 | 2022-06-17 | 2 | |
|
9,000 | 2022-06-17 | 2 | |
|
9,000 | 2022-06-17 | 3 | |
|
9,000 | 2022-06-17 | 1 | |
MAURO DAVID J CHIEF MEDICAL OFFICER |
|
0 | 2022-05-02 | 2 |
WILLIAMS DOUGLAS E PRESIDENT & CEO |
|
153,125 | 2022-02-16 | 2 |
BAIN LINDA CHIEF FINANCIAL OFFICER |
|
50,750 | 2022-02-16 | 2 |
BRUDNICK RICHARD SEE REMARKS |
|
27,125 | 2022-02-16 | 2 |
KONSTANTINOV KONSTANTIN CHIEF TECHNOLOGY OFFICER |
|
28,000 | 2022-02-16 | 2 |
BARNA NICOLE SEE REMARKS |
|
21,000 | 2022-02-16 | 3 |
HOWZE YALONDA SEE REMARKS |
|
32,375 | 2022-02-16 | 2 |
SATHYANARAYANAN SRIRAM CHIEF SCIENTIFIC OFFICER |
|
49,000 | 2022-02-16 | 3 |
SORENSEN BENNY SEE REMARKS |
|
87,411 | 2021-06-08 | 0 |
WHELER JENNIFER J. CHIEF MEDICAL OFFICER |
|
100,000 | 2021-05-10 | 0 |
|
4,761 | 2021-02-17 | 0 | |
VERMA AJAY SEE REMARKS |
|
0 | 2021-01-22 | 0 |
ARCH VENTURE FUND VIII OVERAGE, L.P. |
|
3,854,098 | 2020-10-16 | 0 |
FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC FLAGSHIP VENTURES FUND V, L.P. |
|
2,607,303 | 2020-10-16 | 0 |
|
18,051,580 | 2020-10-16 | 0 | |
|
738,134 | 2020-10-13 | 0 | |
FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC FLAGSHIP VENTURELABS V MANAGER LLC FLAGSHIP VENTURES FUND V, L.P. |
|
485,949 | 2020-10-13 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-06-21 16:43:37 -0400 | 2022-06-17 | A | 7,500 | a | 7,500 | direct | ||||||||||
2022-06-21 16:43:37 -0400 | 2022-06-17 | A | 1,500 | a | 1,500 | direct | ||||||||||
2022-06-21 16:47:41 -0400 | 2022-06-17 | A | 7,500 | a | 7,500 | direct | ||||||||||
2022-06-21 16:47:41 -0400 | 2022-06-17 | A | 1,500 | a | 1,500 | direct | ||||||||||
2022-06-21 16:47:27 -0400 | 2022-06-17 | A | 7,500 | a | 7,500 | direct | ||||||||||
2022-06-21 16:47:27 -0400 | 2022-06-17 | A | 1,500 | a | 1,500 | direct | ||||||||||
2022-06-21 16:45:26 -0400 | 2022-06-17 | A | 7,500 | a | 7,500 | direct | ||||||||||
2022-06-21 16:45:26 -0400 | 2022-06-17 | A | 1,500 | a | 1,500 | direct | ||||||||||
BERNSTEIN KAREN - Director see footnote |
2022-06-21 16:48:27 -0400 | 2022-06-17 | A | 7,500 | a | 7,500 | indirect | |||||||||
BERNSTEIN KAREN - Director see footnote |
2022-06-21 16:48:27 -0400 | 2022-06-17 | A | 1,500 | a | 1,500 | indirect | |||||||||
2022-06-21 16:48:01 -0400 | 2022-06-17 | A | 7,500 | a | 7,500 | direct | ||||||||||
2022-06-21 16:48:01 -0400 | 2022-06-17 | A | 1,500 | a | 1,500 | direct | ||||||||||
2022-06-21 16:51:49 -0400 | 2022-06-17 | A | 7,500 | a | 7,500 | direct | ||||||||||
2022-06-21 16:51:49 -0400 | 2022-06-17 | A | 1,500 | a | 1,500 | direct | ||||||||||
2022-05-04 16:29:09 -0400 | 2022-05-02 | A | 200,000 | a | 200,000 | direct | ||||||||||
2022-05-04 16:29:09 -0400 | 2022-05-02 | A | 20,000 | a | 20,000 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 22:15:03 UTC | 0.167 | 1.403 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 21:45:03 UTC | 0.167 | 1.403 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 21:15:04 UTC | 0.167 | 1.403 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 20:45:03 UTC | 0.1123 | 1.4577 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 20:15:03 UTC | 0.1123 | 1.4577 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 19:45:03 UTC | 0.1123 | 1.4577 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 19:15:03 UTC | 0.1123 | 1.4577 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 18:45:03 UTC | 0.0373 | 1.5327 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 18:15:04 UTC | 0.0373 | 1.5327 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 17:45:03 UTC | 0.0373 | 1.5327 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 17:15:03 UTC | 0.0373 | 1.5327 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 16:45:03 UTC | 0.0373 | 1.5327 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 16:15:03 UTC | 0.0373 | 1.5327 | 300000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 15:45:03 UTC | 0.0373 | 1.5327 | 10000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 15:15:03 UTC | 0.0373 | 1.5327 | 6000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 14:45:03 UTC | 0.5702 | 0.9998 | 6000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 14:15:03 UTC | 0.5702 | 0.9998 | 6000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 13:45:03 UTC | 0.5702 | 0.9998 | 6000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 13:15:03 UTC | 0.5702 | 0.9998 | 6000 |
CODIAK BIOSCIENCES INC CDAK | 2022-06-24 12:45:03 UTC | 0.5702 | 0.9998 | 6000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | CDAK | -300.0 shares, $-1881.0 | 2022-03-31 | N-PORT |